Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Indian Journal of Cancer|March 11, 2016
Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 casesG K Rath, D N Sharma, S Mallick, et al.Indian Journal of Cancer|March 11, 2016
Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care center of IndiaS Mallick, S Roy, S Das, et al.QJM : Monthly Journal of the Association of Physicians|October 2, 2013
Anaphylaxis: incidence, presentation, causes and outcome in patients in a tertiary-care hospital in Karachi, PakistanN U Khan, N Shakeel, A Makda, et al.Indian Journal of Cancer|December 11, 2014
Modern chemoradiation practices for malignant tumors of the trachea: An institutional experienceN Joshi, S Mallick, K P Haresh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1996
Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistryD Y Kuo, S Mallick, H J Shen, et al.Bioresource Technology|October 2, 2013
Constructed wetland as an ecotechnological tool for pollution treatment for conservation of Ganga riverU N Rai, R D Tripathi, N K Singh, et al.American Journal of Ophthalmology|October 9, 2001
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionP A Netland, T Landry, E K Sullivan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.Pageof 8